Posts

Innovative, highly accurate AI model can estimate lung ...

If there is one medical exam that everyone in the world has taken, it’s a chest ...

Nerve damage from breast cancer treatment can be predicted

Many women treated for breast cancer using taxanes, a type of cytostatic drug, o...

Roche Stops Lung Cancer Immunotherapy Trial in Newest D...

The management of Roche has decided to stop the immunotherapy treatment trial fo...

Pentixapharm Acquires Glycotope for its target discover...

In a bid to amp up its radiopharmaceuticals pipeline, Pentixapharm has chosen to...

Braiding community values with science is key to ecosys...

Up on the “roof of the world”, one of the world’s largest ecosystem restoration ...

Hexagonal perovskite oxides: Electrolytes for next-gene...

This study presents a significant advancement in fuel cell technology. Researche...

Visualizing short-lived intermediate compounds produced...

Immobilizing small synthetic molecules inside protein crystals proves to be a pr...

Dalfampridine IR by Solaxa for Spinocerebellar Ataxia (...

Dalfampridine IR is under clinical development by Solaxa and currently in Phase ...

AZD-2389 by AstraZeneca for Metabolic Dysfunction-Assoc...

AZD-2389 is under clinical development by AstraZeneca and currently in Phase I f...

NN-6561 by Novo Nordisk for Metabolic Dysfunction-Assoc...

NN-6561 is under clinical development by Novo Nordisk and currently in Phase I f...

CTX-310 by CRISPR Therapeutics for Heterozygous familia...

CTX-310 is under clinical development by CRISPR Therapeutics and currently in Ph...

CTX-310 by CRISPR Therapeutics for Homozygous Familial ...

CTX-310 is under clinical development by CRISPR Therapeutics and currently in Ph...

CTX-310 by CRISPR Therapeutics for Hypertriglyceridemia...

CTX-310 is under clinical development by CRISPR Therapeutics and currently in Ph...

BNT-325 by Duality Biologics (Shanghai) for Metastatic ...

BNT-325 is under clinical development by Duality Biologics (Shanghai) and curren...

CAN-3110 by Candel Therapeutics for High-Grade Glioma: ...

CAN-3110 is under clinical development by Candel Therapeutics and currently in P...

ICTCAR-028 by Innovative Cellular Therapeutics for Hema...

ICTCAR-028 is under clinical development by Innovative Cellular Therapeutics and...